

[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
Andreas Argyrides Maintained (ASND) at Buy with Decreased Target to $186 on, May 8th, 2023
Andreas Argyrides of Wedbush, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Decreased Target from $195 to $186 on, May 8th, 2023.
Andreas has made no other calls on ASND in the last 4 months.
There are 7 other peers that have a rating on ASND. Out of the 7 peers that are also analyzing ASND, 3 agree with Andreas's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Tiago Fauth of "Credit Suisse" Maintained at Hold with Increased Target to $89 on, Friday, April 28th, 2023
- Vikram Purohit of "Morgan Stanley" Maintained at Hold with Increased Target to $109 on, Friday, April 28th, 2023
- Leland Gershell of "Oppenheimer" Downgraded from Buy to Hold on, Wednesday, April 5th, 2023
These are the ratings of the 4 analyists that currently disagree with Andreas
- Li Watsek of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $152 on, Friday, April 28th, 2023
- David Lebowitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $146 on, Wednesday, April 5th, 2023
- Tazeen Ahmad of "B of A Securities" Maintained at Strong Buy with Decreased Target to $92 on, Tuesday, April 4th, 2023
- Joseph Schwartz of "SVB Leerink" Maintained at Buy with Increased Target to $163 on, Tuesday, January 17th, 2023
Contributing Sources